Prolonged glucocorticoid treatment and secondary prevention in acute respiratory distress syndrome

References

• Rubenfeld GD, Caldwell E, Peabody E et al. Incidence and outcomes of acute lung injury. N. Engl. J. Med.353, 1685–1693 (2005).
   PubMed Web of Science ®Google Scholar
• Angus DC, Clermont G, Linde-Zwirble WT et al. Healthcare costs and long-term outcomes after acute respiratory distress syndrome: a Phase III trial of inhaled nitric oxide. Crit. Care Med.34, 2883–2890 (2006).
   PubMed Web of Science ®Google Scholar
• Meduri GU, Marik PE, Chrousos GP et al. Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med.34, 61–69 (2008).
   PubMed Web of Science ®Google Scholar
• Tang B, Craig J, Eslick G, Seppelt I, McLean A. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit. Care Med.37, 1594–1603 (2009).
   PubMed Web of Science ®Google Scholar
• Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am. Rev. Respir. Dis.138, 720–723 (1988).
   PubMed Web of Science ®Google Scholar
• Meduri GU, Annane D, Chrousos GP, Marik PE, Sinclair SE. Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest136, 1631–1643 (2009).
   PubMed Web of Science ®Google Scholar
• Meduri GU, Muthiah MP, Carratu P, Eltorky M, Chrousos GP. Nuclear factor-κB- and glucocorticoid receptor α-mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation12, 321–338 (2005).
   PubMed Web of Science ®Google Scholar
• Marik PE, Pastores S, Annane D et al. Clinical practice guidelines for the diagnosis and management of corticosteroid insufficiency in critical illness: recommendations of an international task force. Crit. Care Med.36, 1937–1949 (2008).
   PubMed Web of Science ®Google Scholar
• Meduri GU, Tolley EA, Chrousos GP, Stentz F. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome. Evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am. J. Respir. Crit. Care Med.165, 983–991 (2002).
   PubMed Web of Science ®Google Scholar
• Meduri GU, Headley S, Tolley E, Shelby M, Stentz F, Postlethwaite A. Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS. Chest108, 1315–1325 (1995).
   PubMed Web of Science ®Google Scholar
• Annane D, Sebille V, Bellissant E. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit. Care Med.34, 22–30 (2006).
   PubMed Web of Science ®Google Scholar
• Steinberg KP, Hudson LD, Goodman RB et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N. Engl. J. Med.354, 1671–1684 (2006).
   PubMed Web of Science ®Google Scholar
• Confalonieri M, Urbino R, Potena A et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am. J. Respir. Crit. Care Med.171, 242–248 (2005).
   PubMed Web of Science ®Google Scholar
• Meduri GU, Golden E, Freire AX et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest131, 954–963 (2007).
   PubMed Web of Science ®Google Scholar
• Varpula T, Pettila V, Rintala E, Takkunen O, Valtonen V. Late steroid therapy in primary acute lung injury. Intensive Care Med.26, 526–531 (2000).
   PubMed Web of Science ®Google Scholar
• Sinclair SE, Bijoy J, Golden E, Carratu P, Umberger R, Meduri GU. Interleukin-8 and soluble intercellular adhesion molecule-1 during acute respiratory distress syndrome and in response to prolonged methylprednisolone treatment. Minerva Pneumologica45, 93–104 (2006).
   Google Scholar
• Headley AS, Meduri GU, Tolley E, Stentz F. Infections, SIRS, and CARS during ARDS and in response to prolonged glucocorticoid treatment [Abstract]. Am. J. Respir. Crit. Care Med.161, A378 (2000).
   Google Scholar
• Meduri GU, Tolley EA, Chinn A, Stentz F, Postlethwaite A. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am. J. Respir. Crit. Care Med.158, 1432–1441 (1998).
   PubMed Web of Science ®Google Scholar
• Meduri GU. An historical review of glucocorticoid treatment in sepsis. Disease pathophysiology and the design of treatment investigation. Sepsis3, 21–38 (1999).
   Google Scholar
• Meduri GU, Headley S, Kohler G et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1β and IL-6 levels are consistent and efficient predictors of outcome over time. Chest107, 1062–1073 (1995).
   PubMed Web of Science ®Google Scholar
• Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest108, 1303–1314 (1995).
   PubMed Web of Science ®Google Scholar
• Meduri GU, Headley S, Golden E et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome. A randomized controlled trial. JAMA280, 159–165 (1998).
   PubMed Web of Science ®Google Scholar
• Leatherman JW, Fluegel WL, David WS, Davies SF, Iber C. Muscle weakness in mechanically ventilated patients with severe asthma. Am. J. Respir. Crit. Care Med.153, 1686–1690 (1996).
   PubMed Web of Science ®Google Scholar
• Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology105, 244–252 (2006).
   PubMed Web of Science ®Google Scholar
• Weber-Carstens S, Keh D. Bolus or continuous hydrocortisone – that is the question. Crit. Care11, 113 (2007).
   PubMedGoogle Scholar
• Loisa P, Parviainen I, Tenhunen J, Hovilehto S, Ruokonen E. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial. Crit. Care11, R21 (2007).
   Google Scholar
• Meduri GU, Mauldin GL, Wunderink RG et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest106, 221–235 (1994).
   PubMed Web of Science ®Google Scholar
• Hesterberg TW, Last JA. Ozone-induced acute pulmonary fibrosis in rats. Prevention of increased rates of collagen synthesis by methylprednisolone. Am. Rev. Respir. Dis.123, 47–52 (1981).
   PubMed Web of Science ®Google Scholar
• Hakkinen PJ, Schmoyer RL, Witschi HP. Potentiation of butylated-hydroxytoluene-induced acute lung damage by oxygen. Effects of prednisolone and indomethacin. Am. Rev. Respir. Dis.128, 648–651 (1983).
   PubMed Web of Science ®Google Scholar
• Kehrer JP, Klein-Szanto AJ, Sorensen EM, Pearlman R, Rosner MH. Enhanced acute lung damage following corticosteroid treatment. Am. Rev. Respir. Dis.130, 256–261 (1984).
   PubMed Web of Science ®Google Scholar
• Ashbaugh DG, Maier RV. Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Diagnosis and treatment. Arch. Surg.120, 530–535 (1985).
   PubMedGoogle Scholar
• Hooper RG, Kearl RA. Established ARDS treated with a sustained course of adrenocortical steroids. Chest97, 138–143 (1990).
   PubMed Web of Science ®Google Scholar
• Briegel J, Jochum M, Gippner-Steppert C, Thiel M. Immunomodulation in septic shock: hydrocortisone differentially regulates cytokine responses. J. Am. Soc. Nephrol.12(Suppl. 17), S70–S74 (2001).
   Google Scholar
• Keh D, Boehnke T, Weber-Cartens S et al. Immunologic and hemodynamic effects of ‘low-dose’ hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am. J. Respir. Crit. Care Med.167, 512–520 (2003).
   PubMed Web of Science ®Google Scholar
• Nawab Q, Golden E, Confalonieri M, Umberger R, Meduri G. Glucocorticoid treatment in severe community-acquired pneumonia. Am. J. Respir. Crit. Care Med.175, A594 (2007).
   Google Scholar
• Barber AE, Coyle SM, Fischer E et al. Influence of hypercortisolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings. Surgery118, 406–410 (1995).
   PubMedGoogle Scholar
• Broug-Holub E, Kraal G. Dose- and time-dependent activation of rat alveolar macrophages by glucocorticoids. Clin. Exp. Immunol.104, 332–336 (1996).
   PubMedGoogle Scholar
• Fantuzzi G, Demitri MT, Ghezzi P. Differential effect of glucocorticoids on tumour necrosis factor production in mice: up-regulation by early pretreatment with dexamethasone. Clin. Exp. Immunol.96, 166–169 (1994).
   PubMedGoogle Scholar
• Barber AE, Coyle SM, Marano MA et al. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J. Immunol.150, 1999–2006 (1993).
   PubMed Web of Science ®Google Scholar
• Schaaf MJ, Cidlowski JA. Molecular mechanisms of glucocorticoid action and resistance. J. Steroid Biochem. Mol. Biol.83, 37–48 (2002).
   PubMed Web of Science ®Google Scholar
• Cooper MS, Stewart PM. Adrenal insufficiency in critical illness. J. Intensive Care Med.22, 348–362 (2007).
   PubMedGoogle Scholar
• Pustavoitau A, Stevens RD. Mechanisms of neurologic failure in critical illness. Crit. Care Clin.24, 1–24, vii (2008).
   PubMedGoogle Scholar
• Headley AS, Tolley E, Meduri GU. Infections and the inflammatory response in acute respiratory distress syndrome. Chest111, 1306–1321 (1997).
   PubMed Web of Science ®Google Scholar
• Meduri GU. Clinical review: a paradigm shift: the bidirectional effect of inflammation on bacterial growth. Clinical implications for patients with acute respiratory distress syndrome. Crit. Care6, 24–29 (2002).
   PubMedGoogle Scholar
• Weigelt JA, Norcross JF, Borman KR, Snyder WHD. Early steroid therapy for respiratory failure. Arch. Surg.120, 536–540 (1985).
   PubMed Web of Science ®Google Scholar
• Bernard GR, Luce JM, Sprung CL et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N. Engl. J. Med.317, 1565–1570 (1987).
   PubMed Web of Science ®Google Scholar
• Kaufmann I, Briegel J, Schliephake F et al. Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization-dependent neutrophil functions. Intensive Care Med.34, 344–349 (2008).
   PubMed Web of Science ®Google Scholar
• Meduri GU, Kanangat S, Bronze MS et al. Effects of methylprednisolone on intracellular bacterial growth. Clin. Diagn. Lab. Immunol.8, 1156–1163 (2001).
   PubMedGoogle Scholar
• Sibila O, Luna C, Agustí C et al. Effects of corticosteroids an animal model of ventilator-associated pneumonia. Proc. Am. Thorac. Soc.3, A21 (2006).
   PubMedGoogle Scholar
• Stevens RD, Dowdy DW, Michaels RK et al. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med.33, 1876–1891 (2007).
   PubMed Web of Science ®Google Scholar
• Hough CL, Steinberg KP, Thompson BT, Rubenfeld GD, Hudson LD. Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS. Intensive Care Med.35, 63–68 (2009).
   PubMed Web of Science ®Google Scholar
• De Jonghe B, Bastuji-Garin S, Sharshar T, Outin H, Brochard L. Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med.30, 1117–1121 (2004).
   PubMed Web of Science ®Google Scholar
• Fernandes AB, Zin WA, Rocco PR. Corticosteroids in acute respiratory distress syndrome. Braz. J. Med. Biol. Res.38, 147–159 (2005).
   PubMedGoogle Scholar
• Pelosi P, Rocco PR. Glucocorticoid treatment in acute respiratory distress syndrome: friend or foe? In: Yearbook of Intensive Care and Emengency Medicine. Vincent J (Ed.). Springer, Berlin, Germany, 214–223 (2008).
   Google Scholar
• Silva PL, Garcia CS, Maronas PA et al. Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury. Eur. Respir. J.33, 634–645 (2009).
   PubMedGoogle Scholar
• Leite-Junior JH, Garcia CS, Souza-Fernandes AB et al. Methylprednisolone improves lung mechanics and reduces the inflammatory response in pulmonary but not in extrapulmonary mild acute lung injury in mice. Crit. Care Med.36, 2621–2628 (2008).
   PubMedGoogle Scholar
• Lee HS, Lee JM, Kim MS, Kim HY, Hwangbo B, Zo JI. Low-dose steroid therapy at an early phase of postoperative acute respiratory distress syndrome. Ann. Thorac. Surg.79, 405–410 (2005).
   PubMed Web of Science ®Google Scholar
• Keel JB, Hauser M, Stocker R, Baumann PC, Speich R. Established acute respiratory distress syndrome: benefit of corticosteroid rescue therapy. Respiration65, 258–264 (1998).
   PubMedGoogle Scholar
• Huh J, Lim C, Jegal Y et al. The effect of steroid therapy in patients with late ARDS. Tuberc. Respir. Dis.52, 376–384 (2002).
   Google Scholar
• Brower G, Matthay M. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N. Engl. J. Med.342, 1301–1308 (2000).
   PubMed Web of Science ®Google Scholar
• Wiedemann HP, Wheeler AP, Bernard GR et al. Comparison of two fluid-management strategies in acute lung injury. N. Engl. J. Med.354, 2564–2575 (2006).
   PubMed Web of Science ®Google Scholar
• Meduri GU. There is no illumination in speculation. Additional data in support of methylprednisolone treatment in ARDS. Chest132(3), 1097–1100 (2007).
   Google Scholar
• Thompson BT, Ancukiewicz M, Hudson LD, Steinberg KP, Bernard GR. Steroid treatment for persistent ARDS: a word of caution. Crit. Care11, 425 (2007).
   PubMedGoogle Scholar
• Foster JR. Steroids for early acute respiratory distress syndrome: critical appraisal of Meduri GU, Golden E, Freire AX et al.: Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007; 131:954–963. Pediatr. Crit. Care Med. DOI10.1097/PCC.0b013e3181c014eb (2009) (Epub ahead of print).
   Google Scholar
• Cuthbertson BH, Sprung CL, Annane D et al. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med.35, 1868–1876 (2009).
   PubMedGoogle Scholar
• Quispe-Laime AM, Bracco JD, Barberio PA et al. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med.36(1), 33–41 (2010).
   PubMed Web of Science ®Google Scholar
• Blanco-Colio LM, Tunon J, Martin-Ventura JL, Egido J. Anti-inflammatory and immunomodulatory effects of statins. Kidney Int.63, 12–23 (2003).
   PubMed Web of Science ®Google Scholar
• Plenge JK, Hernandez TL, Weil KM et al. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation106, 1447–1452 (2002).
   PubMed Web of Science ®Google Scholar
• Schelling G, Briegel J, Roozendaal B, Stoll C, Rothenhausler HB, Kapfhammer HP. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder in survivors. Biol. Psychiatry50, 978–985 (2001).
   PubMed Web of Science ®Google Scholar
• Schelling G, Kilger E, Roozendaal B et al. Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized study. Biol. Psychiatry55, 627–633 (2004).
   PubMed Web of Science ®Google Scholar